July 24, 2019
Heritage Pharmaceuticals Inc. has resolved its Racketeer Influenced and Corrupt Organizations Act suit against two former executives, a deal that comes on the heels of the company's separate agreements with federal prosecutors over price-fixing claims, according to an order filed Wednesday in New Jersey federal court.
November 14, 2018
Gibson Dunn & Crutcher LLP has withdrawn as counsel for Heritage Pharmaceuticals Inc. in the company's Racketeer Influenced and Corrupt Organizations Act suit against two former executives amid their pending motions to disqualify the firm over its prior ties to them, according to a letter sent by co-counsel to a New Jersey federal judge.
March 22, 2018
Two former Heritage Pharmaceuticals Inc. executives urged a New Jersey federal court Wednesday to disqualify Gibson Dunn & Crutcher LLP as counsel for the company in its Racketeer Influenced and Corrupt Organizations Act suit alleging the men siphoned millions from the business, with the reasons for the disqualification bids filed under seal.
December 14, 2016
The U.S. Department of Justice on Wednesday accused the former top executives of Heritage Pharmaceuticals of plotting to fix prices of antibiotics and diabetes treatments, marking the first charges in the watchdog's criminal probe of the generic drug industry.